Phosphatidylinositol (4,5) bisphosphate regulates HIV-1 Gag targeting to the plasma membrane
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
A critical early event in the HIV type 1 (HIV-1) particle assembly pathway is the targeting of the Gag protein to the site of virus assembly. In many cell types, assembly takes place predominantly at the plasma membrane. Cellular factors that regulate Gag targeting remain undefined. The phosphoinositide phosphatidylinositol (4,5) bisphosphate [PI(4,5)P 2 ] controls the plasma membrane localization of a number of cellular proteins. To explore the possibility that this lipid may be involved in Gag targeting and virus particle production, we overexpressed phosphoinositide 5-phosphatase IV, an enzyme that depletes cellular PI(4,5)P 2 , or overexpressed a constitutively active form of Arf6 (Arf6/Q67L), which induces the formation of PI(4,5)P 2 -enriched endosomal structures. Both approaches severely reduced virus production. Upon 5-phosphatase IV overexpression, Gag was no longer localized on the plasma membrane but instead was retargeted to late endosomes. Strikingly, in cells expressing Arf6/Q67L, Gag was redirected to the PI(4,5)P 2 -enriched vesicles and HIV-1 virions budded into these vesicles. These results demonstrate that PI(4,5)P 2 plays a key role in Gag targeting to the plasma membrane and thus serves as a cellular determinant of HIV-1 particle production.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Gag oligomers then shuttle to the plasma membrane where the basic patch in MA mediates binding to raft-like membrane domains containing phosphatidylinositol-4,5-bisphosphate (PIP2) [18,19].”
From Retrovirus maturation-an extraordinary structural transformation (2016) · cites this paper as [18]
In the citing paper
“Experiments targeted toward depleting (PIP2) in cells have shown Gag localization to intracellular membranes instead of the plasma membrane and severely compromised virus release”
From Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication (2026) · cites this paper as Ono et al. 2004
Citations
Cites
Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., & Martin, M. A. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.284-291.1986 · Cited by 2,834
Automatic and Quantitative Measurement of Protein-Protein Colocalization in Live Cells
Costes, S. V., Daelemans, D., Cho, E. H., Dobbin, Z., Pavlakis, G., & Lockett, S. (2004) · Biophysical Journal · doi:10.1529/biophysj.103.038422 · Cited by 1,424
Self-citationEscola, J.-M., Kleijmeer, M. J., Stoorvogel, W., Griffith, J. M., Yoshie, O., & Geuze, H. J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.32.20121 · Cited by 1,228
Várnai, P., & Balla, T. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.501 · Cited by 859
Honda, A., Nogami, M., Yokozeki, T., Yamazaki, M., Nakamura, H., Watanabe, H., Kawamoto, K., Nakayama, K., Morris, A. J., Frohman, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)81540-8 · Cited by 798
HIV-1 Gag proteins: diverse functions in the virus life cycle
Freed, E. O. (1998) · Virology · doi:10.1006/viro.1998.9398 · Cited by 717
Self-citationPhosphoinositide Regulation of the Actin Cytoskeleton
Yin, H. L., & Janmey, P. A. (2003) · Annual Review of Physiology · doi:10.1146/annurev.physiol.65.092101.142517 · Cited by 660
Phosphoinositide Recognition Domains
Lemmon, M. A. (2003) · Traffic · doi:10.1034/j.1600-0854.2004.00071.x · Cited by 563
Zhou, W., Parent, L. J., Wills, J. W., & Resh, M. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.4.2556-2569.1994 · Cited by 530
ADP-Ribosylation Factor 6 Regulates a Novel Plasma Membrane Recycling Pathway
Radhakrishna, H., & Donaldson, J. G. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.1.49 · Cited by 508
Research works printed but not linked: 1
- Swanstrom R. & Wills J. W. (1997) in Retroviruses eds. Coffin J. M. Hughes S. H. & Varmus H. E. (Cold Spring Harbor Lab. Press Plainview NY) pp. 263-334.
Cited by
Items 201–300 of 642
Robinson, B. A., Reed, J. C., Geary, C. D., Swain, J. V., & Lingappa, J. R. (2014) · Journal of Virology · doi:10.1128/jvi.03609-13 · Cited by 43
Monitoring HIV-1 Assembly in Living Cells: Insights from Dynamic and Single Molecule Microscopy
Inamdar, K., Floderer, C., Favard, C., & Muriaux, D. M. (2019) · Viruses · doi:10.3390/v11010072 · Cited by 43
Roy, N. H., Lambelé, M., Chan, J., Symeonides, M., & Thali, M. (2014) · Journal of Virology · doi:10.1128/jvi.00550-14 · Cited by 42
Monde, K., Chukkapalli, V., & Ono, A. (2011) · Journal of Virology · doi:10.1128/jvi.02266-10 · Cited by 42
Self-citationFull assembly of HIV-1 particles requires assistance of the membrane curvature factor IRSp53
Inamdar, K., Tsai, F., de Poret, A., Dibsy, R., Manzi, J., Mérida, P., Muller, R., Lappalainen, P., Roingeard, P., Mak, J., et al. (2021) · eLife · doi:10.7554/elife.67321 · Cited by 42
Understanding retroviral life cycle and its genomic RNA packaging
Chameettachal, A., Mustafa, F., & Rizvi, T. A. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167924 · Cited by 41
Molecular Biology and Diversification of Human Retroviruses
Meissner, M. E., Talledge, N., & Mansky, L. M. (2022) · Frontiers in Virology · doi:10.3389/fviro.2022.872599 · Cited by 41
Human Ubc9 Contributes to Production of Fully Infectious Human Immunodeficiency Virus Type 1 Virions
Jaber, T., Bohl, C. R., Lewis, G. L., Wood, C. A., West, J. T., & Weldon, R. A. (2009) · Journal of Virology · doi:10.1128/jvi.00237-09 · Cited by 40
Olety, B., Veatch, S. L., & Ono, A. (2015) · Journal of Virology · doi:10.1128/jvi.00794-15 · Cited by 40
Self-citationRegulating The Functions of The HIV-1 Matrix Protein
Hearps, A. C., & Jans, D. A. (2007) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2006.0108 · Cited by 40
Phosphoinositides in the Mammalian Endo-lysosomal Network
Cullen, P. J., & Carlton, J. G. (2012) · Subcellular Biochemistry · doi:10.1007/978-94-007-3015-1_3 · Cited by 40
A Consensus View of ESCRT-Mediated Human Immunodeficiency Virus Type 1 Abscission
Lippincott-Schwartz, J., Freed, E. O., & van Engelenburg, S. B. (2017) · Annual Review of Virology · doi:10.1146/annurev-virology-101416-041840 · Cited by 40
Self-citationMultimerizable HIV Gag derivative binds to the liquid-disordered phase in model membranes
Keller, H., Kräusslich, H., & Schwille, P. (2012) · Cellular Microbiology · doi:10.1111/cmi.12064 · Cited by 40
Inhibition of HIV-1 Gag–membrane interactions by specific RNAs
Todd, G. C., Duchon, A., Inlora, J., Olson, E. D., Musier-Forsyth, K., & Ono, A. (2017) · RNA · doi:10.1261/rna.058453.116 · Cited by 39
“…[PI(4,5)P2], an acidic phospholipid enriched in the inner leaflet of the PM, drive HIV-1 assembly to the PM over other intracellular membranes (Ono et al. 2004; Saad et al. 2006; Shkriabai et al. 2006; Chan et al. 2008; Chukkapalli et al. 2008; Alfadhli et al. 2009; Anraku et al. 2010; Monde…”
BackgroundSelf-citationMechanisms of PI(4,5)P2 Enrichment in HIV-1 Viral Membranes
Wen, Y., Feigenson, G. W., Vogt, V. M., & Dick, R. A. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.07.018 · Cited by 39
HIV-1 Gag: An Emerging Target for Antiretroviral Therapy
Tedbury, P. R., & Freed, E. O. (2015) · Current topics in microbiology and immunology · doi:10.1007/82_2015_436 · Cited by 39
Self-citationVisualizing fusion of pseudotyped HIV-1 particles in real time by live cell microscopy
Koch, P., Lampe, M., Godinez, W. J., Müller, B., Rohr, K., Kräusslich, H., & Lehmann, M. J. (2009) · Retrovirology · doi:10.1186/1742-4690-6-84 · Cited by 39
Sette, P., O’Connor, S. K., Yerramilli, V. S., Dussupt, V., Nagashima, K., Chutiraka, K., Lingappa, J. R., Scarlata, S., & Bouamr, F. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.02.004 · Cited by 39
Self-citationHIV-1 RNA genome packaging: it’s G-rated
Duchon, A. A., & Hu, W.-S. (2024) · mBio · doi:10.1128/mbio.00861-23 · Cited by 39
Harrist, A. V., Ryzhova, E. V., Harvey, T., & González-Scarano, F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005020 · Cited by 38
HIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors
Spearman, P. W. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150902102143 · Cited by 38
Human Immunodeficiency Virus Type-1 Gag and Host Vesicular Trafficking Pathways
Chu, H., Wang, J.-J., & Spearman, P. W. (2009) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-02175-6_4 · Cited by 38
7SL RNA Is Retained in HIV-1 Minimal Virus-Like Particles as an S-Domain Fragment
Keene, S. E., King, S. R., & Telesnitsky, A. (2010) · Journal of Virology · doi:10.1128/jvi.00714-10 · Cited by 38
Joshi, A., Garg, H., Ablan, S. D., & Freed, E. O. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.241521 · Cited by 38
Self-citationRequirement for microtubule integrity in the SOCS1‐mediated intracellular dynamics of HIV‐1 Gag
Nishi, M., Ryo, A., Tsurutani, N., Ohba, K., Sawasaki, T., Morishita, R., Perrem, K., Aoki, I., Morikawa, Y., & Yamamoto, N. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.03.041 · Cited by 38
HIV-1 Matrix Dependent Membrane Targeting Is Regulated by Gag mRNA Trafficking
Jin, J., Sturgeon, T., Weisz, O. A., Mothes, W., & Montelaro, R. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006551 · Cited by 37
New Insights into HTLV-1 Particle Structure, Assembly, and Gag-Gag Interactions in Living Cells
Fogarty, K., Zhang, W., Grigsby, I. F., Johnson, J. L., Chen, Y., Mueller, J. D., & Mansky, L. M. (2011) · Viruses · doi:10.3390/v3060770 · Cited by 37
Dick, R. A., Kamynina, E., & Vogt, V. M. (2013) · Journal of Virology · doi:10.1128/jvi.01659-13 · Cited by 37
Thornhill, D., Olety, B., & Ono, A. (2019) · Journal of Virology · doi:10.1128/jvi.00756-19 · Cited by 37
Self-citationImportance of viral late domains in budding and release of enveloped RNA viruses
Welker, L., Paillart, J.-C., & Bernacchi, S. (2021) · Viruses · doi:10.3390/v13081559 · Cited by 36
“The latter is composed by a myristic acid moiety, and a highly basic region (HBR) located on the surface of MA domain, which forms electrostatic interactions with negatively charged phosphatidylinositol-(4,5)-bisphosphate (PIP2) that are specifically enriched at the inner leaflet of PM [41].”
BackgroundAnalysis of HIV-1 Matrix-Envelope Cytoplasmic Tail Interactions
Alfadhli, A., Staubus, A. O., Tedbury, P. R., Novikova, M., Freed, E. O., & Barklis, E. (2019) · Journal of Virology · doi:10.1128/jvi.01079-19 · Cited by 36
Self-citationRetroviral Env Glycoprotein Trafficking and Incorporation into Virions
Murakami, T. (2012) · Molecular Biology International · doi:10.1155/2012/682850 · Cited by 36
Yan, B., Zou, Z., Chu, H., Chan, G., Tsang, J. O., Lai, P.-M., Yuan, S., Yip, C. C., Yin, F., Kao, R. Y. T., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235952 · Cited by 36
Nadaraia-Hoke, S., Bann, D. V., Lochmann, T. L., Gudleski-O'Regan, N., & Parent, L. J. (2013) · Journal of Virology · doi:10.1128/jvi.03059-12 · Cited by 36
The roles of lipids and nucleic acids in HIV-1 assembly
Alfadhli, A., & Barklis, E. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00253 · Cited by 35
Methods for the Study of HIV-1 Assembly
Waheed, A. A., Ono, A., & Freed, E. O. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-170-3_12 · Cited by 35
Self-citationSolution Structure of Calmodulin Bound to the Binding Domain of the HIV-1 Matrix Protein
Vlach, J., Samal, A. B., & Saad, J. S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.543694 · Cited by 34
Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities
Alfadhli, A., Mack, A. R., Ritchie, C., Cylinder, I., Harper, L., Tedbury, P. R., Freed, E. O., & Barklis, E. (2016) · Journal of Virology · doi:10.1128/jvi.00509-16 · Cited by 34
Self-citationEhrlich, L. S., Medina, G. N., Khan, M. B., Powell, M. D., Mikoshiba, K., & Carter, C. A. (2010) · Journal of Virology · doi:10.1128/jvi.01588-09 · Cited by 34
Structural and molecular determinants of HIV-1 Gag binding to the plasma membrane
Vlach, J., & Saad, J. S. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00232 · Cited by 33
FIV Gag: Virus assembly and host-cell interactions
Luttge, B. G., & Freed, E. O. (2009) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2009.10.003 · Cited by 33
Self-citationThe Cytoplasmic Tail of Retroviral Envelope Glycoproteins
Tedbury, P. R., & Freed, E. O. (2014) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.10.009 · Cited by 33
Self-citationBasic Motifs Target PSGL-1, CD43, and CD44 to Plasma Membrane Sites Where HIV-1 Assembles
Grover, J. R., Veatch, S. L., & Ono, A. (2014) · Journal of Virology · doi:10.1128/jvi.02178-14 · Cited by 33
Self-citationThe Src Kinase Lck Facilitates Assembly of HIV-1 at the Plasma Membrane
Strasner, A., Natarajan, M., Doman, T., Key, D., August, A., & Henderson, A. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3706 · Cited by 33
Yeager, M. J. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.073 · Cited by 32
Beyond Plasma Membrane Targeting: Role of the MA domain of Gag in Retroviral Genome Encapsidation
Parent, L. J., & Gudleski-O'Regan, N. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.072 · Cited by 32
Tedbury, P. R., Mercredi, P. Y., Gaines, C. R., Summers, M. F., & Freed, E. O. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.01.018 · Cited by 32
Self-citationParveen, N., Borrenberghs, D., Rocha, S., & Hendrix, J. (2018) · Viruses · doi:10.3390/v10050250 · Cited by 31
Investigation of the Lipid Binding Properties of the Marburg Virus Matrix Protein VP40
Wijesinghe, K. J., & Stahelin, R. V. (2015) · Journal of Virology · doi:10.1128/jvi.02607-15 · Cited by 31
Bouard, D., Sandrin, V., Boson, B., Négre, D., Thomas, G., Granier, C., & Cosset, F. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00581.x · Cited by 31
The Interplay between HIV-1 Gag Binding to the Plasma Membrane and Env Incorporation
Murphy, R. E., & Saad, J. S. (2020) · Viruses · doi:10.3390/v12050548 · Cited by 30
“These results were later explained by the discovery that Gag localization on the PM is highly dependent on a specific interaction between the HBR and phosphatidylinositol 4,5‐bisphosphate (PI(4,5)P2) [15,16,24,58], a minor PM lipid that 2.”
BackgroundDiscovery of a small-molecule antiviral targeting the HIV-1 matrix protein
Zentner, I., Sierra, L., Maciunas, L. J., Vinnik, A., Fedichev, P. O., Mankowski, M. K., Ptak, R. G., Martín‐García, J., & Cocklin, S. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.11.041 · Cited by 30
Arii, J., Fukui, A., Shimanaka, Y., Kono, N., Arai, H., Maruzuru, Y., Koyanagi, N., Kato, A., Mori, Y., & Kawaguchi, Y. (2020) · Journal of Virology · doi:10.1128/jvi.01572-20 · Cited by 30
Relationship between HIV-1 Gag Multimerization and Membrane Binding
Sumner, C. A., & Ono, A. (2022) · Viruses · doi:10.3390/v14030622 · Cited by 30
Self-citationBrandano, L., & Stevenson, M. (2012) · Journal of Virology · doi:10.1128/jvi.06047-11 · Cited by 30
Lipids in infectious diseases – The case of AIDS and tuberculosis
Dumas, F., & Haanappel, E. (2017) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2017.05.007 · Cited by 30
Urano, E., Aoki, T., Futahashi, Y., Murakami, T., Morikawa, Y., Yamamoto, N., & Komano, J. A. (2008) · Journal of General Virology · doi:10.1099/vir.0.2008/004820-0 · Cited by 29
de ROCQUIGNY, H., Meshri, S. E. E., Richert, L., Didier, P., Darlix, J., & Mély, Y. (2014) · Virus Research · doi:10.1016/j.virusres.2014.06.009 · Cited by 29
Yan, B., Yuan, S., Cao, J., Fung, K., Lai, P.-M., Yin, F., Sze, K. H., Qin, Z., Xie, Y., Ye, Z., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.73057 · Cited by 29
Recent advances in HIV-1 Gag inhibitor design and development
Dick, A., & Cocklin, S. (2020) · Molecules · doi:10.3390/molecules25071687 · Cited by 28
Cross- and Co-Packaging of Retroviral RNAs and Their Consequences
Ali, L., Rizvi, T., & Mustafa, F. (2016) · Viruses · doi:10.3390/v8100276 · Cited by 28
Samal, A. B., Ghanam, R. H., Fernandez, T. F., Monroe, E. B., & Saad, J. S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.273623 · Cited by 28
Role of Glycosphingolipids in Dendritic Cell-Mediated HIV-1 Trans-infection
Puryear, W. B., & Gummuluru, S. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4433-6_5 · Cited by 28
Analysis of Small Molecule Ligands Targeting the HIV-1 Matrix Protein-RNA Binding Site
Alfadhli, A., McNett, H., Eccles, J. D., Tsagli, S. M., Noviello, C., Sloan, R., López, C. S., Peyton, D. H., & Barklis, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.399865 · Cited by 27
NMR Structure of the Myristylated Feline Immunodeficiency Virus Matrix Protein
Brown, L., Cox, C., Brown, J. B., Summers, H., Button, R., Bahlow, K., Spurrier, V., Kyser, J., Luttge, B. G., Kuo, L. S., et al. (2015) · Viruses · doi:10.3390/v7052210 · Cited by 27
Self-citationAnnexin A2: the missing piece in the puzzle of pathogen-induced damage
Li, C., Yu, J., Liao, D., Su, X., Yi, X., Yang, X. F., & He, J. (2023) · Virulence · doi:10.1080/21505594.2023.2237222 · Cited by 27
Pak, A. J., Gupta, M., Yeager, M. J., & Voth, G. A. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c02568 · Cited by 27
Analysis of human immunodeficiency virus matrix domain replacements
Scholz, I., Still, A., Dhenub, T. C., Coday, K., Webb, M., & Barklis, E. (2007) · Virology · doi:10.1016/j.virol.2007.10.010 · Cited by 27
Mansouri, K., Rastegari‐Pouyani, M., Ghanbari-Movahed, M., Safarzadeh, M., Kiani, S., & Ghanbari‐Movahed, Z. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110694 · Cited by 26
Caccuri, F., Iaria, M. L., Campilongo, F., Varney, K. M., Rossi, A., Mitola, S. M. F., Schiarea, S., Bugatti, A., Mazzuca, P., Giagulli, C., et al. (2016) · Scientific Reports · doi:10.1038/srep38027 · Cited by 26
Defect of Human Immunodeficiency Virus Type 2 Gag Assembly in Saccharomyces cerevisiae
Morikawa, Y., Goto, T., Yasuoka, D., Momose, F., & Matano, T. (2007) · Journal of Virology · doi:10.1128/jvi.00027-07 · Cited by 26
Bhatia, A. K., Campbell, N., Panganiban, A. T., & Ratner, L. (2007) · Virology · doi:10.1016/j.virol.2007.06.046 · Cited by 26
Dadhich, R., & Kapoor, S. (2020) · The Journal of Membrane Biology · doi:10.1007/s00232-020-00135-0 · Cited by 26
Revisiting Membrane Microdomains and Phase Separation: A Viral Perspective
Sengupta, P., & Lippincott‐Schwartz, J. (2020) · Viruses · doi:10.3390/v12070745 · Cited by 26
Effects of Membrane Charge and Order on Membrane Binding of the Retroviral Structural Protein Gag
Wen, Y., Dick, R. A., Feigenson, G. W., & Vogt, V. M. (2016) · Journal of Virology · doi:10.1128/jvi.01102-16 · Cited by 25
Viral Determinants of Polarized Assembly for the Murine Leukemia Virus
Jin, J., Li, F., & Mothes, W. (2011) · Journal of Virology · doi:10.1128/jvi.00409-11 · Cited by 25
Raut, P., Weller, S. R., Obeng, B., Soos, B.-L., West, B. E., Potts, C. M., Sangroula, S., Kinney, M. S., Burnell, J. E., King, B. L., et al. (2021) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.115913 · Cited by 25
An overview of intracellular interactions between immunodeficiency viruses and their hosts
Bieniasz, P. D. (2012) · AIDS · doi:10.1097/qad.0b013e328353bd04 · Cited by 25
Une nouvelle vision de l’assemblage du VIH-1
Corbin, A., Grigorov, B., Roingeard, P., Darlix, J., & Muriaux, D. M. (2008) · médecine/sciences · doi:10.1051/medsci/200824149 · Cited by 25
HIV-1 diverts cortical actin for particle assembly and release
Dibsy, R., Brémaud, E., Mak, J., Favard, C., & Muriaux, D. M. (2023) · Nature Communications · doi:10.1038/s41467-023-41940-0 · Cited by 25
Viruses and phospholipids: Friends and foes during infection
Rattay, S., Hufbauer, M., Hoboth, P., Sztacho, M., & Akgũl, B. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28658 · Cited by 25
Inhibition of Early Stages of HIV-1 Assembly by INI1/hSNF5 Transdominant Negative Mutant S6
Cano, J., & Kalpana, G. V. (2010) · Journal of Virology · doi:10.1128/jvi.00006-10 · Cited by 25
Liang, G., Zhao, L., Qiao, Y., Geng, W., Zhang, X., Liu, M., Dong, J., Ding, H., Sun, H., & Shang, H. (2019) · Nature Immunology · doi:10.1038/s41590-019-0385-2 · Cited by 24
Budding of Retroviruses Utilizing Divergent L Domains Requires Nucleocapsid
Bello, N. F., Dussupt, V., Sette, P., Rudd, V., Nagashima, K., Bibollet-Ruche, F., Chen, C., Montelaro, R. C., Hahn, B. H., & Bouamr, F. (2012) · Journal of Virology · doi:10.1128/jvi.07105-11 · Cited by 24
“plasma membrane (11, 34, 59, 79), whereas the CA domain carries”
BackgroundSelf-citationAtomic view of the HIV-1 matrix lattice; implications on virus assembly and envelope incorporation
Samal, A. B., Green, T. J., & Saad, J. S. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2200794119 · Cited by 24
Kakisaka, M., Yamada, K. D., Yamaji‐Hasegawa, A., Kobayashi, T., & Aida, Y. (2016) · Virology · doi:10.1016/j.virol.2016.05.018 · Cited by 24
Liu, L., Sutton, J. A., Woodruff, E. A., Villalta, F., Spearman, P. W., & Dong, X. (2012) · Journal of Virology · doi:10.1128/jvi.00544-12 · Cited by 24
Smith, E. M., Macdonald, P. J., Chen, Y., & Mueller, J. D. (2014) · Biophysical Journal · doi:10.1016/j.bpj.2014.04.055 · Cited by 24
Coleman, E. M., Walker, T. N., & Hildreth, J. E. K. (2012) · Virology Journal · doi:10.1186/1743-422x-9-31 · Cited by 23
Murphy, R. E., Samal, A. B., Vlach, J., Mas, V., Prevelige, P. E., & Saad, J. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010997 · Cited by 23
Zhou, Y., Rong, L., Lu, J., Pan, Q., & Liang, C. (2008) · Journal of Virology · doi:10.1128/jvi.00189-08 · Cited by 23
Ceramide synthase 2 deletion decreases the infectivity of HIV-1
Barklis, E., Alfadhli, A., Kyle, J. E., Bramer, L., Bloodsworth, K., Barklis, R. L., Leier, H. C., Petty, R. M., Zelnik, I. D., Metz, T., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100340 · Cited by 23
Yoo, S., Waheed, A. A., Deme, P., Tohumeken, Ş., Rais, R., Smith, M. D., DeMarino, C., Calabresi, P. A., Kashanchi, F., Freed, E. O., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2219543120 · Cited by 22
Self-citationDostálková, A., Kaufman, F., Křížová, I., Vokatá, B., Ruml, T., & Rumlová, M. (2020) · Journal of Virology · doi:10.1128/jvi.00991-20 · Cited by 22
ESCRT Machinery Potentiates HIV-1 Utilization of the PI(4,5)P2-PLC-IP3R-Ca2+ Signaling Cascade
Ehrlich, L. S., Medina, G. N., & Carter, C. A. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.08.038 · Cited by 22
Jalaguier, P., Turcotte, K., Danylo, A., Cantin, R., & Tremblay, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028314 · Cited by 22
The “basics” of HIV-1 assembly
Sumner, C. A., & Ono, A. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011937 · Cited by 21
Self-citationDefects in cellular sorting and retroviral assembly induced by GGA overexpression
Joshi, A., Nagashima, K., & Freed, E. O. (2009) · BMC Cell Biology · doi:10.1186/1471-2121-10-72 · Cited by 21
Self-citationInlora, J., Chukkapalli, V., Bedi, S., & Ono, A. (2016) · Journal of Virology · doi:10.1128/jvi.01004-16 · Cited by 21
Self-citationA Comparative Portrait of Retroviral Fusogens and Syncytins
Pérot, P., Montgiraud, C., Lavillette, D., & Mallet, F. (2010) · Springer eBooks · doi:10.1007/978-90-481-9772-9_4 · Cited by 21
Metadata
- Authors
- Ono, A., Ablan, S. D., Lockett, S. J., Nagashima, K., & Freed, E. O.
- Affiliations
- Frederick National Laboratory for Cancer Research (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2004-10
- Volume
- 101
- Issue
- 41
- Pages
- 14889-14894
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC522033
- OpenAlex
- W2057712924
- Cited by
- 553
- References
- 56
- Citations by year
- 2026: 12 · 2025: 22 · 2024: 33 · 2023: 13 · 2022: 25 · 2021: 26 · 2020: 27 · 2019: 24 · 2018: 20 · 2017: 15 · 2016: 25 · 2015: 28 · 2014: 32 · 2013: 28 · 2012: 32
- FWCI
- 6.63
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- HIV-1, Gag protein, phosphatidylinositol 4,5-bisphosphate, viral assembly, plasma membrane targeting, ARF6, late endosomes, viral budding, lipid signaling
- MeSH terms
- Cell Membrane, HeLa Cells, Humans, Macrophages, Virus Replication, HIV-1, Gene Products, gag, Phosphatidylinositol 4,5-Diphosphate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.